Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20211101052938N1
IRCT20211101052938N1
Completed
Phase 3

Comparison of the effect of oral progesterone and vaginal progesterone on luteal phase support using available drugs in IVF/ICSI candidates

Zanjan University of Medical Sciences0 sites160 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIn vitro fertilization.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
In vitro fertilization.
Sponsor
Zanjan University of Medical Sciences
Enrollment
160
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •IVF/ICSI candidate with history of infertility
  • •age between 18 to 40 years old
  • •have an informed consent to participate in the study

Exclusion Criteria

  • •drug reaction history to one of the drugs used in this study
  • •endocrine or metabolic disorders
  • •endometriosis
  • •Azospermia of partner
  • •uterine anatomic anomaly
  • •history of 2 or more unsuccessful IVF or FET
  • •history of repetitive spontaneous abortion

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of progesterone on pregnancy rate of assisted reproductioOther complications associated with artificial fertilization.Noninflammatory disorders of female genital tract
IRCT2014071212494N2Vice chancellor for research, Shahid Beheshti University of Medical Science300
Recruiting
Phase 3
Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsia
IRCT20210127050156N1Karaj University of Medical Sciences80
Active, not recruiting
Phase 1
Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone therapy – a double-blind randomized study- PROBES study (Progesterone Breast Endometrial Safety study)Climacteric symptomsTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2021-001624-17-SEKarolinska University Hospital520
Completed
Phase 1
Effect of oral progesterone versus placebo on reducing preterm labor in women with a history of preterm labor
IRCT201710079014N192Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences214
Completed
Not Applicable
Evaluation of treatment with progesterone in controlled ovarian stimulation for patients undergoing IVF/ICSI cycles to prevent ovulation: a randomized clinical trialInfertility
JPRN-UMIN000035469Hanabusa Womens' clinic50